Fluidigm Announces $250 Million Strategic Capital Infusion
Mission to Reinvigorate Growth through Optimization of Mass Cytometry and Microfluidics Platforms and Portfolio Expansion via Strategic Acquisitions ...
Source: globenewswire.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Microfluidics Platforms. Real-time updates on events, politics, business and more.